BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 12871882)

  • 1. Serum and cyst fluid levels of interleukin (IL) -6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours.
    Daraï E; Detchev R; Hugol D; Quang NT
    Hum Reprod; 2003 Aug; 18(8):1681-5. PubMed ID: 12871882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do endometriomas induce an inflammatory reaction in nearby follicles?
    Opøien HK; Fedorcsak P; Polec A; Stensen MH; Åbyholm T; Tanbo T
    Hum Reprod; 2013 Jul; 28(7):1837-45. PubMed ID: 23543385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies.
    Sipak-Szmigiel O; Włodarski P; Ronin-Walknowska E; Niedzielski A; Karakiewicz B; Słuczanowska-Głąbowska S; Laszczyńska M; Malinowski W
    J Ovarian Res; 2017 Apr; 10(1):25. PubMed ID: 28376925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum cytokines in patients with ovarian cancer and benign ovarian cysts].
    Nowak M; Szpakowski M; Malinowski A; Wieczorek A; Maciołek-Blewniewska G; Wilczyński JR; Szpakowski A; Wierzbicka E; Małafiej E; Oszukowski P
    Ginekol Pol; 2001 Dec; 72(12A):1444-8. PubMed ID: 11883294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of interleukin-1 beta and tumour necrosis factor-alpha in patients with benign or malignant ovarian tumours.
    Punnonen J; Heinonen PK; Kuoppala T; Jansen CT; Punnonen R
    J Cancer Res Clin Oncol; 1991; 117(6):587-92. PubMed ID: 1744165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Intracystic Cytokines and Nitric Oxide in Ovarian Neoplasms.
    Martins-Filho A; Jammal MP; Micheli DC; Tavares-Murta BM; Etchebehere RM; Murta EFC; Nomelini RS
    Scand J Immunol; 2017 Dec; 86(6):462-470. PubMed ID: 28960399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL6, IL8, and IL10 in the distinction of malignant ovarian neoplasms and endometriomas.
    Crispim PCA; Jammal MP; Antão PKA; Micheli DC; Tavares-Murta BM; Murta EFC; Nomelini RS
    Am J Reprod Immunol; 2020 Dec; 84(6):e13309. PubMed ID: 32698242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proinflammatory and immunosuppressive serum, ascites and cyst fluid cytokines in patients with early and advanced ovarian cancer and benign ovarian tumors.
    Nowak M; Glowacka E; Szpakowski M; Szyllo K; Malinowski A; Kulig A; Tchorzewski H; Wilczynski J
    Neuro Endocrinol Lett; 2010; 31(3):375-83. PubMed ID: 20588232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical importance of determination of cytokines in patients with ovary tumours.
    Abdullaeva LM
    Lik Sprava; 2010; (3-4):56-9. PubMed ID: 21261134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cadherins and CD44 isoforms in ovarian endometrial cysts.
    Daraï E; Leblanc M; Walker-Combrouze F; Bringuier AF; Madelenat P; Scoazec JY
    Hum Reprod; 1998 May; 13(5):1346-52. PubMed ID: 9647570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine profiles in cyst fluids from ovarian tumors reflect immunosuppressive state of the tumor.
    Yigit R; Massuger LF; Zusterzeel PL; Pots J; Figdor CG; Torensma R
    Int J Gynecol Cancer; 2011 Oct; 21(7):1241-7. PubMed ID: 21946293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cytokines and CXCR2: potential tumour markers in ovarian neoplasms.
    Micheli DC; Jammal MP; Martins-Filho A; Côrtes JRXM; Souza CN; Nomelini RS; Murta EFC; Tavares-Murta BM
    Biomarkers; 2020 Sep; 25(6):474-482. PubMed ID: 32544350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of apoptosis-related proteins in endometriomas and benign and malignant ovarian tumours.
    Fauvet R; Poncelet C; Hugol D; Lavaur A; Feldmann G; Daraï E
    Virchows Arch; 2003 Jul; 443(1):38-43. PubMed ID: 12756564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines in peritoneal fluid of ovarian neoplasms.
    de Lima CA; Silva Rodrigues IS; Martins-Filho A; Côbo Micheli D; Martins Tavares-Murta B; Candido Murta EF; Simões Nomelini R
    J Obstet Gynaecol; 2020 Apr; 40(3):401-405. PubMed ID: 31476946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer.
    Moradi MM; Carson LF; Weinberg B; Haney AF; Twiggs LB; Ramakrishnan S
    Cancer; 1993 Oct; 72(8):2433-40. PubMed ID: 8402460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of cyst puncture in the differential diagnosis of benign ovarian tumours.
    Vercellini P; Oldani S; Felicetta I; Bramante T; Rognoni MT; Crosignani PG
    Hum Reprod; 1995 Jun; 10(6):1465-9. PubMed ID: 7593516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chemotactic cytokine interleukin-8--a cyst fluid marker for malignant epithelial ovarian cancer?
    Ivarsson K; Runesson E; Sundfeldt K; Haeger M; Hedin L; Janson PO; Brännström M
    Gynecol Oncol; 1998 Dec; 71(3):420-3. PubMed ID: 9887242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum soluble CD163 and interleukin-6 levels in women with ovarian endometriomas.
    Jee BC; Suh CS; Kim SH; Moon SY
    Gynecol Obstet Invest; 2008; 66(1):47-52. PubMed ID: 18311079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma urocortin levels in the diagnosis of ovarian endometriosis.
    Florio P; Reis FM; Torres PB; Calonaci F; Toti P; Bocchi C; Linton EA; Petraglia F
    Obstet Gynecol; 2007 Sep; 110(3):594-600. PubMed ID: 17766605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does cytokine profiling of aspirate from jaw cysts and tumors have a role in diagnosis?
    Kolokythas A; Karas M; Sarna T; Flick W; Miloro M
    J Oral Maxillofac Surg; 2012 May; 70(5):1070-80. PubMed ID: 21802820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.